Skip to main content
SpringerLink
Log in

Diagnostics for Aspirin Resistance

  • Commentary
  • Published:
Molecular Diagnosis & Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Reilly IA, FitzGerald GA. Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs. Blood 1987; 69: 180–6

    PubMed  CAS  Google Scholar 

  2. Tantry US, Bliden KP, Gurbel PA. Resistance to antiplatelet drugs: current status and future research. Expert Opin Pharmacother 2005; 6: 2027–45

    Article  PubMed  CAS  Google Scholar 

  3. Gurbel PA, Bliden KP, DiChiara J, et al. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Circulation 2007; 115: 3156–64

    Article  PubMed  CAS  Google Scholar 

  4. DiChiara J, Bliden KP, Tantry US, et al. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study. Diabetes 2007; 56: 3014–9

    Article  PubMed  CAS  Google Scholar 

  5. Snoep JD, Hovens MM, Eikenboom JC, et al. Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis. Arch Intern Med 2007; 167: 1593–9

    Article  PubMed  Google Scholar 

  6. Eikelboom JW, Hirsh J, Weitz JI, et al. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 2002; 105: 1650–5

    Article  PubMed  CAS  Google Scholar 

  7. Johnston M, Wentworth S, Lauzon M, et al. Comparision of two assays for the emasurement of urinary 11-dehydrothromboxane B2. J Thromb Haemost 2007; 5Suppl. 2: P–M–330

    Google Scholar 

Download references

Acknowledgments

Dr Gurbel has received research grant and honoraria from Bayer, Astrazeneca, Schering Plough, Eli Lily, and Daiichi/Sankyo.

Drs Bilden and Tantry have no conflicts of interest that are directly relevant to the content of this commentary.

Author information

Authors and Affiliations

  1. Sinai Center for Thrombosis Research, Hoffberger Building, Suite 56, 2401 W. Belvedere Ave, Baltimore, MD, 21215, USA

    Paul A. Gurbel, Kevin P. Bilden & Udaya S. Tantry

Authors
  1. Paul A. Gurbel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kevin P. Bilden
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Udaya S. Tantry
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul A. Gurbel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gurbel, P.A., Bilden, K.P. & Tantry, U.S. Diagnostics for Aspirin Resistance. Mol Diag Ther 12, 55–56 (2008). https://doi.org/10.1007/BF03256269

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03256269

Keywords

Search

Navigation